Position in LH
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$10,094,840
+$399,499 QoQ
Shares Held
36,053
-0.8% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#170
of 1,040 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Korea Investment CORP holds $343,476,278 across 12 Diagnostics & Research names. LH ranks #9 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
277,446 | $139,100,326 | |
| 2 | DHR |
Danaher Corp /De/
|
415,041 | $79,057,009 | |
| 3 | NTRA |
Natera, Inc.
|
72,864 | $19,778,932 | |
| 4 | WAT |
Waters Corp /De/
|
49,296 | $18,487,971 | |
| 5 | ILMN |
Illumina, Inc.
|
91,843 | $16,148,754 | |
| 6 | A |
Agilent Technologies, Inc.
|
116,190 | $15,433,517 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
72,030 | $13,917,636 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
25,513 | $13,431,063 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,094,840 | 36,053 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $9,695,341 | 36,338 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $9,437,603 | 37,618 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $9,145,157 | 31,858 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $6,131,708 | 23,358 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $7,531,000 | 32,358 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $8,498,140 | 37,058 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $6,091,617 | 27,258 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,898,844 | 19,158 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||